DK141926B - Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. - Google Patents

Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. Download PDF

Info

Publication number
DK141926B
DK141926B DK9775AA DK9775A DK141926B DK 141926 B DK141926 B DK 141926B DK 9775A A DK9775A A DK 9775AA DK 9775 A DK9775 A DK 9775A DK 141926 B DK141926 B DK 141926B
Authority
DK
Denmark
Prior art keywords
strain
virus
atcc
serum
eggs
Prior art date
Application number
DK9775AA
Other languages
Danish (da)
English (en)
Other versions
DK141926C (de
DK9775A (de
Inventor
Michele Lobmann
Julien Peetermans
Jean-Marie Prevost
Emil Vascoboinic
Original Assignee
Rit Rech Ind Therapeut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rit Rech Ind Therapeut filed Critical Rit Rech Ind Therapeut
Publication of DK9775A publication Critical patent/DK9775A/da
Publication of DK141926B publication Critical patent/DK141926B/da
Application granted granted Critical
Publication of DK141926C publication Critical patent/DK141926C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK9775AA 1974-02-04 1975-01-16 Fremgangsmåde til fremstilling af en svækket influenzavirusstamme. DK141926B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43917674A 1974-02-04 1974-02-04
US43917674 1974-02-04

Publications (3)

Publication Number Publication Date
DK9775A DK9775A (de) 1975-09-29
DK141926B true DK141926B (da) 1980-07-21
DK141926C DK141926C (de) 1981-01-19

Family

ID=23743623

Family Applications (1)

Application Number Title Priority Date Filing Date
DK9775AA DK141926B (da) 1974-02-04 1975-01-16 Fremgangsmåde til fremstilling af en svækket influenzavirusstamme.

Country Status (21)

Country Link
JP (1) JPS50107122A (de)
AT (1) AT338416B (de)
BE (1) BE824970A (de)
CA (1) CA1047922A (de)
CH (1) CH596316A5 (de)
CS (1) CS202545B2 (de)
DD (1) DD116474A5 (de)
DE (1) DE2504373A1 (de)
DK (1) DK141926B (de)
ES (1) ES434384A1 (de)
FI (1) FI750260A (de)
FR (1) FR2259616B1 (de)
GB (1) GB1439742A (de)
HU (1) HU170522B (de)
IE (1) IE42043B1 (de)
IL (1) IL46446A (de)
LU (1) LU71784A1 (de)
NL (1) NL7501028A (de)
NO (1) NO750295L (de)
SE (1) SE424503B (de)
ZA (1) ZA75248B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2588918A (en) * 1947-11-07 1952-03-11 William T Graham Mechanism for raising and lowering plow frames relative to the ground wheels
JPS6042209B2 (ja) * 1974-05-31 1985-09-20 北里研究所（社団法人） インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法

Also Published As

Publication number Publication date
NL7501028A (nl) 1975-08-06
IL46446A (en) 1978-01-31
CS202545B2 (en) 1981-01-30
CA1047922A (en) 1979-02-06
FR2259616A1 (de) 1975-08-29
DD116474A5 (de) 1975-11-20
ES434384A1 (es) 1976-12-01
GB1439742A (en) 1976-06-16
FI750260A (de) 1975-08-05
AT338416B (de) 1977-08-25
IE42043B1 (en) 1980-05-21
BE824970A (fr) 1975-07-30
AU7734675A (en) 1976-07-15
DK141926C (de) 1981-01-19
ZA75248B (en) 1976-01-28
LU71784A1 (de) 1975-06-24
ATA76675A (de) 1976-12-15
DK9775A (de) 1975-09-29
NO750295L (de) 1975-09-01
CH596316A5 (de) 1978-03-15
SE7500549L (de) 1975-08-05
JPS50107122A (de) 1975-08-23
DE2504373A1 (de) 1975-08-07
SE424503B (sv) 1982-07-26
IE42043L (en) 1975-08-04
HU170522B (de) 1977-06-28
FR2259616B1 (de) 1980-01-04
IL46446A0 (en) 1975-04-25

Similar Documents

Publication Publication Date Title
Pensaert et al. Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man
Beare et al. Replication of avian influenza viruses in humans
Takada et al. Avirulent Avian influenza virus as a vaccine strain against a potential human pandemic
Kodihalli et al. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines
AU770923B2 (en) Inactivated influenza virus vaccine for nasal or oral administration
Ruben et al. A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity
Oxford et al. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection
RU2547589C2 (ru) Новый птичий астровирус
US4009258A (en) Influenza vaccine containing a recombinant, antigenically hybridized virus and method of using the same
Cox et al. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: Nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25° between recent H3N2 and H1N1 epidemic strains and cold-adapted A/Ann Arbor/6/60
US5162112A (en) Influenza vaccine
Pensaert et al. Vaccination of chickens against a Belgian nephropathogenic strain of infectious bronchitis virus B1648 using attenuated homologous and heterologous strains
US4318903A (en) Live influenza virus vaccine and the preparation thereof
US3953592A (en) Live influenza virus vaccines and preparation thereof
AU2002253542B2 (en) Purified subfragment encoding neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis
Romanova et al. Interference between cold-adapted (ca) influenza A and B vaccine reassortants or between ca reassortants and wild-type strains in eggs and mice
US3962423A (en) Live influenza type B virus vaccines and preparation thereof
DK141926B (da) Fremgangsmåde til fremstilling af en svækket influenzavirusstamme.
CS199569B2 (en) Method of producing vaccine against influenza
CA1152895A (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
CN111647610B (zh) 一种互换ha和ns1缺失基因包装信号的h9n2亚型禽流感病毒及其构建方法和应用
US4206287A (en) Vaccines and their preparation
CA2388054C (en) Compositions and methods for stimulating an immune response against infectious agents
Numazaki et al. A variant of parainfluenza type 2 virus
RU2323741C2 (ru) Вакцина против гриппа птиц инактивированная эмульсионная

Legal Events

Date Code Title Description
PBP Patent lapsed